However, in support of the COBLL1 role in metabolic disease, our study not only demonstrates fat-depot-specific COBLL1 mRNA expression, but also a significantly lower COBLL1 expression in sc AT of patients with T2D. This evidence concerns the gene COBLL1 and type 2 diabetes mellitus.